Studies have shown that miR‐23b‐3p can serve as a preventive measure for autoimmune diseases by focusing on SOX6 and blocking the NF‐κB signaling pathway, thereby alleviating SS symptoms [181]. Here, NFKB1 is linked to synovial sarcoma.